Navigation Links
Agendia's Breast Cancer Recurrence Test MammaPrint Included in International St. Gallen Expert Consensus Recommendations
Date:6/23/2009

y also offers TargetPrint to further improve breast cancer treatment options. TargetPrint quantitatively determines the gene expression levels of HER2neu, estrogen and progesterone receptors. Ongoing research and development efforts continue to augment Agendia's ability to accurately predict breast cancer recurrence, and help physicians tailor individual treatment plans to their patients.

    For online access to the Annals of Oncology:
http://annonc.oxfordjournals.org/cgi/content/full/mdp322v1

About Agendia

Agendia is at the forefront of the personalized medicine revolution, striving to bring more effective, individualized treatment within reach of patients. Building on a cutting edge genomics platform for tumor gene expression profiling, the company's tests aim to help physicians more accurately tailor cancer therapy. The company markets four products, with several new genomic tests in development. Agendia collaborates with pharmaceutical companies in the development of highly effective personalized drugs in the area of oncology and was awarded the 2008 North American Oncology Clinical Diagnostics Healthcare Innovation Award by Frost & Sullivan. Agendia is based in Huntington Beach, California, and in Amsterdam, The Netherlands. For more information please visit http://www.agendia.com.


'/>"/>
SOURCE Agendia B.V.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine technology :

1. CuraGen Announces Expansion of CR011-vcMMAE Phase II Trial in Advanced Breast Cancer
2. Investigational Cancer Drug BSI-201 Showed Clinical Benefit in 62% of Patients with Triple-Negative Metastatic Breast Cancer and Significantly Prolonged Survival
3. New Study: Antidepressants Commonly Prescribed with Tamoxifen Put Women at Much Higher Risk for Recurrent Breast Cancer
4. New Research Shows Antidepressants May Thwart Breast Cancer Treatment
5. Scientists at The Karmanos Cancer Institute in Detroit Identify Potential New Target for Breast Cancer Therapy
6. New Preliminary Data from Two Studies Show Clinical Activity of Neratinib in Combination with Trastuzumab and in Combination with Paclitaxel in Advanced HER-2 Positive Breast Cancer
7. Genomic Health Study Shows Breast Cancers in Men Display Very Similar Gene Signatures to Those in Women
8. Hooters of Orange Park to Host Charity Car Wash Raising Money for Breast Cancer Research
9. Peregrine Pharmaceuticals Completes Patient Enrollment in its Phase II Trial of Bavituximab Plus Docetaxel in Breast Cancer Patients
10. Karmanos Cancer Institute Researchers Present Breast Cancer Advancements at Conference
11. ExonHit Reports Proof-of-Concept in Breast Cancer Diagnostic Using its SpliceArray(TM) Platform
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/14/2009)... According to Millennium Research Group (MRG), the global ... of safety devices for small-bore connectors for disposable ... of the enteral feeding device markets in both ... and European Markets for Enteral Feeding Devices 2010 ... will experience the greatest impact from facilities switching ...
(Date:12/14/2009)... Dec. 14 Mylan Inc. (Nasdaq: ... be added to the NASDAQ-100 Index Dec. 21. ... NASDAQ,s PowerShares QQQ. ,, Mylan Chairman and CEO ... to join NASDAQ,s most widely followed index of ... milestone for Mylan and reflects the rapid growth ...
(Date:12/14/2009)... Pf enex Inc. announced today that ... affiliate, an exclusive worldwide license to Pf enex ... for the production of specific proteins to ... candidate. ,, Under the terms of the agreement ... million in upfront and milestone payments as well as ...
Breaking Medicine Technology:Enteral Feeding Device Market To Generate More Than $700 Million in the US & Europe by 2014 2Enteral Feeding Device Market To Generate More Than $700 Million in the US & Europe by 2014 3Mylan Added to NASDAQ-100 Index 2Laser processes promise better artificial joints arterial stents 9932 1Laser processes promise better artificial joints arterial stents 9932 2Laser processes promise better artificial joints arterial stents 9932 3Survey Finds Overwhelming Majority of Americans Believe Special Interests Hindering Health Care Reform 57211 1Survey Finds Overwhelming Majority of Americans Believe Special Interests Hindering Health Care Reform 57211 2Seniors in Medicare Advantage Receive Higher Quality Care New Reports Show 57206 1Seniors in Medicare Advantage Receive Higher Quality Care New Reports Show 57206 2Seniors in Medicare Advantage Receive Higher Quality Care New Reports Show 57206 3
... ... Stent, ... ) today announced that it has completed enrollment in,the PERSEUS trial, ... PERSEUS,clinical program has enrolled nearly 1,500 patients at 100 U.S. and,international ...
... shows clinical improvement in patients with pulmonary ... benefit for this debilitating, rapidly progressive and ... Gleevec(R) for treatment of certain cancers, known ... further explore potential of imatinib mesylate in PAH in ...
Other Medicine Technology:Boston Scientific Completes Clinical Trial Enrollment for Third-Generation Drug-Eluting Stent 2Boston Scientific Completes Clinical Trial Enrollment for Third-Generation Drug-Eluting Stent 3Boston Scientific Completes Clinical Trial Enrollment for Third-Generation Drug-Eluting Stent 4Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 2Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 3Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 4Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 5Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 6Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 7Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 8Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 9Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 10Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 11Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 12
(Date:12/14/2009)... activities like housework, gardening replaced tube watching , , MONDAY, ... 25 or 26 hours of television a week until ... cut his tube time in half. , During his ... each day, and not necessarily through strenuous exercise, although ... his newly freed time was spent reading and working ...
(Date:12/14/2009)... Marc Sedwitz Heads up 900-Member Physician Staff , ... ... La Jolla have elected Marc Sedwitz, MD, as the new chief ... as head of the 900-member physician team on Jan. 1, 2010. ... serve as medical staff liaison to Scripps La Jolla’s administrative staff ...
(Date:12/14/2009)... -- Skilled nursing facilities (SNFs) in Ohio are making ... deal with a 92 percent increase in the state-imposed ... $12.01 per bed per day, scheduled for December 15. ... pay an additional $17,520 to the state each month, ... $438,365 yearly. ,, Nearly 96 percent of skilled nursing ...
(Date:12/14/2009)... Critical to Stemming Tide of Tens of Thousands ... WASHINGTON, Dec. 14 Legislation approved by ... will be crucial in helping to reduce tens ... each year in the United States, the ... The provision was included in the FY ...
(Date:12/14/2009)... WASHINGTON, Dec. 14 The Hemophilia Federation ... ongoing labor issues involving the Teamsters Local 929 ... Jersey. The national blood system depends on skilled ... The blood is distilled into products such as ... von Willebrand disease. ,, The Division of ...
Breaking Medicine News(10 mins):Health News:Cutting TV Time Burns More Calories 2Health News:New Chief of Staff Takes Over at Scripps Memorial Hospital La Jolla 2Health News:New Chief of Staff Takes Over at Scripps Memorial Hospital La Jolla 3Health News:Survey Shows Tax Increase Forcing Ohio Skilled Nursing Facilities to Make Cuts 2Health News:Survey Shows Tax Increase Forcing Ohio Skilled Nursing Facilities to Make Cuts 3Health News:NVHR Applauds Congressional Action to End Federal Ban on Funding Syringe Exchange 2Health News:HFA Voices Blood Safety Concerns 2
... Add Understanding Not Confusion, FOLSOM, Calif., Feb. 20 ... of California Walnut Commission: Given the state of the,national ... choices is clear. We welcome new independent nutrition rating ... packaging. While some fear,that this will be confusing, our ...
... a New Era of Clean Slumber and an Industry ... ... CleanRest(R), an industry,leading innovator that creates and develops products devoted to improving,the ... World,s Cleanest Pillow(TM)" featuring MicronOne(TM),technology. This news ends a year of tremendous ...
... Varian Medical,Systems (NYSE: VAR ) is ... RapidArc(TM) radiotherapy technology for faster and more,precise cancer ... more about a technology that makes it possible ... eight,times faster than is possible with conventional IMRT ...
... American Stroke Associations International Stroke Conference 2008 to be ... Convention Center in New Orleans, La. , This ... scientists and physicians engaged in research and treatment of ... United States. Nearly 4,000 attendees are expected. ...
... Racial Minorities, the Uninsured and,Medicare Patients, ... revealing,decreasing trends in cancer deaths in the ... in particular, highlight the remarkable benefits,of colorectal ... of these,tests is unrealized for many Americans, ...
... 19 On November 5, 2007, under increasing,government pressure, ... of its drug Trasylol after a Canadian clinical study,found ... of death than other drugs.,The Food and Drug Administration ... prevent excessive bleeding during heart bypass surgery,pending detailed review ...
Other Medicine News:Health News:Walnuts Rank High on New Nutrition Scales 2Health News:Walnuts Rank High on New Nutrition Scales 3Health News:CleanRest(R) Announces a Groundbreaking Invention, The World's Cleanest Pillow(TM) 2Health News:CleanRest(R) Announces a Groundbreaking Invention, The World's Cleanest Pillow(TM) 3Health News:Varian Medical Systems Announces Symposia on RapidArc Technology for Faster, More Precise Radiotherapy Treatments 2Health News:Varian Medical Systems Announces Symposia on RapidArc Technology for Faster, More Precise Radiotherapy Treatments 3Health News:U.S. Cancer Deaths Down But Far Too Few Americans Screened for Colon Cancer 2Health News:U.S. Cancer Deaths Down But Far Too Few Americans Screened for Colon Cancer 3Health News:U.S. Cancer Deaths Down But Far Too Few Americans Screened for Colon Cancer 4Health News:Randone Trasylol Lawsuit Profiled on CBS' '60 Minutes' 2Health News:Randone Trasylol Lawsuit Profiled on CBS' '60 Minutes' 3Health News:Randone Trasylol Lawsuit Profiled on CBS' '60 Minutes' 4
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: